APO Research
Talk to an analyst

APO RESEARCH · REPORT

Musculoskeletal System Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Musculoskeletal System Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025190 pages

Choose your research edition.

Industry ResearchMusculoskeletal System Disorder Drug Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Musculoskeletal System Disorder Drug Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Musculoskeletal System Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Musculoskeletal System Disorder Drug Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Musculoskeletal System Disorder Drug Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Musculoskeletal System Disorder Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Musculoskeletal System Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Musculoskeletal System Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Musculoskeletal System Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Musculoskeletal System Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Musculoskeletal System Disorder Drug include Sanofi, Johnson & Johnson, Novartis, Eli Lilly, Pfizer, AbbVie, Torrent Pharmaceuticals, Nippon Shinyaku and Merck & Co, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Musculoskeletal System Disorder Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Musculoskeletal System Disorder Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Musculoskeletal System Disorder Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Musculoskeletal System Disorder Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Musculoskeletal System Disorder Drug Segment by Company

Sanofi

Johnson & Johnson

Novartis

Eli Lilly

Pfizer

AbbVie

Torrent Pharmaceuticals

Nippon Shinyaku

Merck & Co

GSK

Eisai

Cadila Healthcare

Bayer

Astellas Pharma

Asahi Kasei

Amgen

Abbott

Musculoskeletal System Disorder Drug Segment by Type

Bone Disorder

Joint Disorder

Muscle Disorder

Other

Musculoskeletal System Disorder Drug Segment by Application

Hospital & Clinic

Retail Pharmacy

Other

Musculoskeletal System Disorder Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Musculoskeletal System Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Musculoskeletal System Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Musculoskeletal System Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Musculoskeletal System Disorder Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Musculoskeletal System Disorder Drug industry.

Chapter 3: Detailed analysis of Musculoskeletal System Disorder Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Musculoskeletal System Disorder Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Musculoskeletal System Disorder Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Bone Disorder Table 3. Key Players of Joint Disorder Table 4. Key Players of Muscle Disorder Table 3. Key Players of Other Table 4. Global Musculoskeletal System Disorder Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital & Clinic Table 6. Key Players of Retail Pharmacy Table 7. Key Players of Other Table 8. Global Musculoskeletal System Disorder Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Musculoskeletal System Disorder Drug Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Musculoskeletal System Disorder Drug Market Share by Region (2021-2026) Table 11. Global Musculoskeletal System Disorder Drug Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Musculoskeletal System Disorder Drug Market Share by Region (2027-2032) Table 13. Musculoskeletal System Disorder Drug Industry Trends Table 14. Musculoskeletal System Disorder Drug Industry Drivers Table 15. Musculoskeletal System Disorder Drug Industry Opportunities and Challenges Table 16. Musculoskeletal System Disorder Drug Industry Restraints Table 17. Global Musculoskeletal System Disorder Drug Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Musculoskeletal System Disorder Drug Revenue Market Share by Company (2021-2026) Table 19. Global Musculoskeletal System Disorder Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Musculoskeletal System Disorder Drug Key Company Head Office and Area Served Table 21. Global Musculoskeletal System Disorder Drug Company, Product Type & Application Table 22. Global Musculoskeletal System Disorder Drug Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Musculoskeletal System Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Musculoskeletal System Disorder Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Musculoskeletal System Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Musculoskeletal System Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Musculoskeletal System Disorder Drug Revenue Market Share by Type (2021-2026) Table 29. Global Musculoskeletal System Disorder Drug Revenue Market Share by Type (2027-2032) Table 30. Global Musculoskeletal System Disorder Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Musculoskeletal System Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Musculoskeletal System Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Musculoskeletal System Disorder Drug Revenue Market Share by Application (2021-2026) Table 34. Global Musculoskeletal System Disorder Drug Revenue Market Share by Application (2027-2032) Table 35. Sanofi Company Information Table 36. Sanofi Business Overview Table 37. Sanofi Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Sanofi Musculoskeletal System Disorder Drug Product Portfolio Table 39. Sanofi Recent Development Table 40. Johnson & Johnson Company Information Table 41. Johnson & Johnson Business Overview Table 42. Johnson & Johnson Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Johnson & Johnson Musculoskeletal System Disorder Drug Product Portfolio Table 44. Johnson & Johnson Recent Development Table 45. Novartis Company Information Table 46. Novartis Business Overview Table 47. Novartis Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Novartis Musculoskeletal System Disorder Drug Product Portfolio Table 49. Novartis Recent Development Table 50. Eli Lilly Company Information Table 51. Eli Lilly Business Overview Table 52. Eli Lilly Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Eli Lilly Musculoskeletal System Disorder Drug Product Portfolio Table 54. Eli Lilly Recent Development Table 55. Pfizer Company Information Table 56. Pfizer Business Overview Table 57. Pfizer Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Pfizer Musculoskeletal System Disorder Drug Product Portfolio Table 59. Pfizer Recent Development Table 60. AbbVie Company Information Table 61. AbbVie Business Overview Table 62. AbbVie Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. AbbVie Musculoskeletal System Disorder Drug Product Portfolio Table 64. AbbVie Recent Development Table 65. Torrent Pharmaceuticals Company Information Table 66. Torrent Pharmaceuticals Business Overview Table 67. Torrent Pharmaceuticals Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Torrent Pharmaceuticals Musculoskeletal System Disorder Drug Product Portfolio Table 69. Torrent Pharmaceuticals Recent Development Table 70. Nippon Shinyaku Company Information Table 71. Nippon Shinyaku Business Overview Table 72. Nippon Shinyaku Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Nippon Shinyaku Musculoskeletal System Disorder Drug Product Portfolio Table 74. Nippon Shinyaku Recent Development Table 75. Merck & Co Company Information Table 76. Merck & Co Business Overview Table 77. Merck & Co Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Merck & Co Musculoskeletal System Disorder Drug Product Portfolio Table 79. Merck & Co Recent Development Table 80. GSK Company Information Table 81. GSK Business Overview Table 82. GSK Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. GSK Musculoskeletal System Disorder Drug Product Portfolio Table 84. GSK Recent Development Table 85. Eisai Company Information Table 86. Eisai Business Overview Table 87. Eisai Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Eisai Musculoskeletal System Disorder Drug Product Portfolio Table 89. Eisai Recent Development Table 90. Cadila Healthcare Company Information Table 91. Cadila Healthcare Business Overview Table 92. Cadila Healthcare Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Cadila Healthcare Musculoskeletal System Disorder Drug Product Portfolio Table 94. Cadila Healthcare Recent Development Table 95. Bayer Company Information Table 96. Bayer Business Overview Table 97. Bayer Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Bayer Musculoskeletal System Disorder Drug Product Portfolio Table 99. Bayer Recent Development Table 100. Astellas Pharma Company Information Table 101. Astellas Pharma Business Overview Table 102. Astellas Pharma Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Astellas Pharma Musculoskeletal System Disorder Drug Product Portfolio Table 104. Astellas Pharma Recent Development Table 105. Asahi Kasei Company Information Table 106. Asahi Kasei Business Overview Table 107. Asahi Kasei Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Asahi Kasei Musculoskeletal System Disorder Drug Product Portfolio Table 109. Asahi Kasei Recent Development Table 110. Amgen Company Information Table 111. Amgen Business Overview Table 112. Amgen Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Amgen Musculoskeletal System Disorder Drug Product Portfolio Table 114. Amgen Recent Development Table 115. Abbott Company Information Table 116. Abbott Business Overview Table 117. Abbott Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Abbott Musculoskeletal System Disorder Drug Product Portfolio Table 119. Abbott Recent Development Table 120. North America Musculoskeletal System Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 121. North America Musculoskeletal System Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 122. North America Musculoskeletal System Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 123. North America Musculoskeletal System Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 124. North America Musculoskeletal System Disorder Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Musculoskeletal System Disorder Drug Market Size by Country (2021-2026) Table 126. North America Musculoskeletal System Disorder Drug Market Size by Country (2027-2032) Table 127. Europe Musculoskeletal System Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 128. Europe Musculoskeletal System Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 129. Europe Musculoskeletal System Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 130. Europe Musculoskeletal System Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 131. Europe Musculoskeletal System Disorder Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Musculoskeletal System Disorder Drug Market Size by Country (2021-2026) Table 133. Europe Musculoskeletal System Disorder Drug Market Size by Country (2027-2032) Table 134. China Musculoskeletal System Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 135. China Musculoskeletal System Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 136. China Musculoskeletal System Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 137. China Musculoskeletal System Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 138. Asia Musculoskeletal System Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 139. Asia Musculoskeletal System Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 140. Asia Musculoskeletal System Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 141. Asia Musculoskeletal System Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 142. Asia Musculoskeletal System Disorder Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Musculoskeletal System Disorder Drug Market Size by Country (2021-2026) Table 144. Asia Musculoskeletal System Disorder Drug Market Size by Country (2027-2032) Table 145. South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 146. South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 147. South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 148. South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 149. South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2021-2026) Table 151. South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Musculoskeletal System Disorder Drug Product Image Figure 2. Global Musculoskeletal System Disorder Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Musculoskeletal System Disorder Drug Market Share by Type: 2025 VS 2032 Figure 4. Bone Disorder Image Figure 5. Joint Disorder Image Figure 6. Muscle Disorder Image Figure 7. Other Image Figure 8. Global Musculoskeletal System Disorder Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Musculoskeletal System Disorder Drug Market Share by Application: 2025 VS 2032 Figure 10. Hospital & Clinic Image Figure 11. Retail Pharmacy Image Figure 12. Other Image Figure 13. Global Musculoskeletal System Disorder Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 15. Global Musculoskeletal System Disorder Drug Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Musculoskeletal System Disorder Drug Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Musculoskeletal System Disorder Drug Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Musculoskeletal System Disorder Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Musculoskeletal System Disorder Drug Revenue Market Share by Type (2021-2032) Figure 22. Global Musculoskeletal System Disorder Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Musculoskeletal System Disorder Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 25. North America Musculoskeletal System Disorder Drug Market Share by Type (2021-2032) Figure 26. North America Musculoskeletal System Disorder Drug Market Share by Application (2021-2032) Figure 27. North America Musculoskeletal System Disorder Drug Market Share by Country (2021-2032) Figure 28. United States Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 29. Canada Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe Musculoskeletal System Disorder Drug Market Share by Type (2021-2032) Figure 33. Europe Musculoskeletal System Disorder Drug Market Share by Application (2021-2032) Figure 34. Europe Musculoskeletal System Disorder Drug Market Share by Country (2021-2032) Figure 35. Germany Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 36. France Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 38. Italy Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 39. Russia Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 42. China Musculoskeletal System Disorder Drug Market Share by Type (2021-2032) Figure 43. China Musculoskeletal System Disorder Drug Market Share by Application (2021-2032) Figure 44. Asia Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 45. Asia Musculoskeletal System Disorder Drug Market Share by Type (2021-2032) Figure 46. Asia Musculoskeletal System Disorder Drug Market Share by Application (2021-2032) Figure 47. Asia Musculoskeletal System Disorder Drug Market Share by Country (2021-2032) Figure 48. Japan Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 52. India Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 53. Australia Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Share by Country (2021-2032) Figure 58. Brazil Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 63. UAE Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 65. Chile Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Bone Disorder
  • Joint Disorder
  • Muscle Disorder
  • Other
Applications
  • Hospital & Clinic
  • Retail Pharmacy
  • Other
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Eli Lilly
  • Pfizer
  • AbbVie
  • Torrent Pharmaceuticals
  • Nippon Shinyaku
  • Merck & Co
  • GSK
  • Eisai
  • Cadila Healthcare
  • Bayer
  • Astellas Pharma
  • Asahi Kasei
  • Amgen
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Musculoskeletal System Disorder Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Bone Disorder
  5. 1.2.3 Joint Disorder
  6. 1.2.4 Muscle Disorder
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Musculoskeletal System Disorder Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital & Clinic
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Musculoskeletal System Disorder Drug Growth Trends by Region
  15. 1.5.1 Global Musculoskeletal System Disorder Drug Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Musculoskeletal System Disorder Drug Market Size by Region (2021-2026)
  17. 1.5.3 Musculoskeletal System Disorder Drug Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Musculoskeletal System Disorder Drug Market Dynamics
  1. 2.1 Musculoskeletal System Disorder Drug Industry Trends
  2. 2.2 Musculoskeletal System Disorder Drug Industry Drivers
  3. 2.3 Musculoskeletal System Disorder Drug Industry Opportunities and Challenges
  4. 2.4 Musculoskeletal System Disorder Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Musculoskeletal System Disorder Drug Revenue by Company (2021-2026)
  2. 3.2 Global Musculoskeletal System Disorder Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Musculoskeletal System Disorder Drug Key Company Head office and Area Served
  4. 3.4 Global Musculoskeletal System Disorder Drug Company, Product Type & Application
  5. 3.5 Global Musculoskeletal System Disorder Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Musculoskeletal System Disorder Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Musculoskeletal System Disorder Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Musculoskeletal System Disorder Drug Tier 1, Tier 2, and Tier 3
4 Musculoskeletal System Disorder Drug Market by Type
  1. 4.1 Global Musculoskeletal System Disorder Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Musculoskeletal System Disorder Drug Market Size by Type (2021-2032)
  3. 4.3 Global Musculoskeletal System Disorder Drug Market Size Share by Type (2021-2032)
5 Musculoskeletal System Disorder Drug Market by Application
  1. 5.1 Global Musculoskeletal System Disorder Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Musculoskeletal System Disorder Drug Market Size by Application (2021-2032)
  3. 5.3 Global Musculoskeletal System Disorder Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi Musculoskeletal System Disorder Drug Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson & Johnson Musculoskeletal System Disorder Drug Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis Musculoskeletal System Disorder Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Eli Lilly
  20. 6.4.1 Eli Lilly Company Information
  21. 6.4.2 Eli Lilly Business Overview
  22. 6.4.3 Eli Lilly Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Eli Lilly Musculoskeletal System Disorder Drug Product Portfolio
  24. 6.4.5 Eli Lilly Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pfizer Musculoskeletal System Disorder Drug Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 AbbVie Musculoskeletal System Disorder Drug Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
  37. 6.7 Torrent Pharmaceuticals
  38. 6.7.1 Torrent Pharmaceuticals Company Information
  39. 6.7.2 Torrent Pharmaceuticals Business Overview
  40. 6.7.3 Torrent Pharmaceuticals Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Torrent Pharmaceuticals Musculoskeletal System Disorder Drug Product Portfolio
  42. 6.7.5 Torrent Pharmaceuticals Recent Developments
  43. 6.8 Nippon Shinyaku
  44. 6.8.1 Nippon Shinyaku Company Information
  45. 6.8.2 Nippon Shinyaku Business Overview
  46. 6.8.3 Nippon Shinyaku Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Nippon Shinyaku Musculoskeletal System Disorder Drug Product Portfolio
  48. 6.8.5 Nippon Shinyaku Recent Developments
  49. 6.9 Merck & Co
  50. 6.9.1 Merck & Co Company Information
  51. 6.9.2 Merck & Co Business Overview
  52. 6.9.3 Merck & Co Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Merck & Co Musculoskeletal System Disorder Drug Product Portfolio
  54. 6.9.5 Merck & Co Recent Developments
  55. 6.10 GSK
  56. 6.10.1 GSK Company Information
  57. 6.10.2 GSK Business Overview
  58. 6.10.3 GSK Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 GSK Musculoskeletal System Disorder Drug Product Portfolio
  60. 6.10.5 GSK Recent Developments
  61. 6.11 Eisai
  62. 6.11.1 Eisai Company Information
  63. 6.11.2 Eisai Business Overview
  64. 6.11.3 Eisai Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Eisai Musculoskeletal System Disorder Drug Product Portfolio
  66. 6.11.5 Eisai Recent Developments
  67. 6.12 Cadila Healthcare
  68. 6.12.1 Cadila Healthcare Company Information
  69. 6.12.2 Cadila Healthcare Business Overview
  70. 6.12.3 Cadila Healthcare Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Cadila Healthcare Musculoskeletal System Disorder Drug Product Portfolio
  72. 6.12.5 Cadila Healthcare Recent Developments
  73. 6.13 Bayer
  74. 6.13.1 Bayer Company Information
  75. 6.13.2 Bayer Business Overview
  76. 6.13.3 Bayer Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Bayer Musculoskeletal System Disorder Drug Product Portfolio
  78. 6.13.5 Bayer Recent Developments
  79. 6.14 Astellas Pharma
  80. 6.14.1 Astellas Pharma Company Information
  81. 6.14.2 Astellas Pharma Business Overview
  82. 6.14.3 Astellas Pharma Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Astellas Pharma Musculoskeletal System Disorder Drug Product Portfolio
  84. 6.14.5 Astellas Pharma Recent Developments
  85. 6.15 Asahi Kasei
  86. 6.15.1 Asahi Kasei Company Information
  87. 6.15.2 Asahi Kasei Business Overview
  88. 6.15.3 Asahi Kasei Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Asahi Kasei Musculoskeletal System Disorder Drug Product Portfolio
  90. 6.15.5 Asahi Kasei Recent Developments
  91. 6.16 Amgen
  92. 6.16.1 Amgen Company Information
  93. 6.16.2 Amgen Business Overview
  94. 6.16.3 Amgen Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Amgen Musculoskeletal System Disorder Drug Product Portfolio
  96. 6.16.5 Amgen Recent Developments
  97. 6.17 Abbott
  98. 6.17.1 Abbott Company Information
  99. 6.17.2 Abbott Business Overview
  100. 6.17.3 Abbott Musculoskeletal System Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Abbott Musculoskeletal System Disorder Drug Product Portfolio
  102. 6.17.5 Abbott Recent Developments
7 North America
  1. 7.1 North America Musculoskeletal System Disorder Drug Market Size (2021-2032)
  2. 7.2 North America Musculoskeletal System Disorder Drug Market Size by Type
  3. 7.2.1 North America Musculoskeletal System Disorder Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Musculoskeletal System Disorder Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Musculoskeletal System Disorder Drug Market Share by Type (2021-2032)
  6. 7.3 North America Musculoskeletal System Disorder Drug Market Size by Application
  7. 7.3.1 North America Musculoskeletal System Disorder Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Musculoskeletal System Disorder Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Musculoskeletal System Disorder Drug Market Share by Application (2021-2032)
  10. 7.4 North America Musculoskeletal System Disorder Drug Market Size by Country
  11. 7.4.1 North America Musculoskeletal System Disorder Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Musculoskeletal System Disorder Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Musculoskeletal System Disorder Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Musculoskeletal System Disorder Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Musculoskeletal System Disorder Drug Market Size (2021-2032)
  2. 8.2 Europe Musculoskeletal System Disorder Drug Market Size by Type
  3. 8.2.1 Europe Musculoskeletal System Disorder Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Musculoskeletal System Disorder Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Musculoskeletal System Disorder Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Musculoskeletal System Disorder Drug Market Size by Application
  7. 8.3.1 Europe Musculoskeletal System Disorder Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Musculoskeletal System Disorder Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Musculoskeletal System Disorder Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Musculoskeletal System Disorder Drug Market Size by Country
  11. 8.4.1 Europe Musculoskeletal System Disorder Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Musculoskeletal System Disorder Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Musculoskeletal System Disorder Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Musculoskeletal System Disorder Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Musculoskeletal System Disorder Drug Market Size (2021-2032)
  2. 9.2 China Musculoskeletal System Disorder Drug Market Size by Type
  3. 9.2.1 China Musculoskeletal System Disorder Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Musculoskeletal System Disorder Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Musculoskeletal System Disorder Drug Market Share by Type (2021-2032)
  6. 9.3 China Musculoskeletal System Disorder Drug Market Size by Application
  7. 9.3.1 China Musculoskeletal System Disorder Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Musculoskeletal System Disorder Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Musculoskeletal System Disorder Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Musculoskeletal System Disorder Drug Market Size (2021-2032)
  2. 10.2 Asia Musculoskeletal System Disorder Drug Market Size by Type
  3. 10.2.1 Asia Musculoskeletal System Disorder Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Musculoskeletal System Disorder Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Musculoskeletal System Disorder Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Musculoskeletal System Disorder Drug Market Size by Application
  7. 10.3.1 Asia Musculoskeletal System Disorder Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Musculoskeletal System Disorder Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Musculoskeletal System Disorder Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Musculoskeletal System Disorder Drug Market Size by Country
  11. 10.4.1 Asia Musculoskeletal System Disorder Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Musculoskeletal System Disorder Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Musculoskeletal System Disorder Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Musculoskeletal System Disorder Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Musculoskeletal System Disorder Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst